This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Novo-Gesic

Starting date:
March 14, 2013
Posting date:
April 2, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-26483

Recalled Products

  1. Novo-Gesic

Reason

Teva Canada initiated the voluntary recall due to potential microbial contamination of the product.

Depth of distribution

Recall to retail level: Distribution in Canada

Affected products

A. Novo-Gesic

DIN, NPN, DIN-HIM
DIN 00389218
Dosage form
  • Tablet
Strength
  • 325 mg
Lot or serial number
  • 35329880G
Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Novopharm Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Date modified: